Results 51 to 60 of about 8,048 (187)

Emerging respiratory viral infections: MERS-CoV and influenza [PDF]

open access: yes, 2014
This article is made available for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source.
Al-Tawfiq, Jaffar A., Memish, Ziad A.
core   +1 more source

Consensus definitions of 14 severe acute toxic effects for childhood lymphoblastic leukaemia treatment: a Delphi consensus [PDF]

open access: yes, 2016
Although there are high survival rates for children with acute lymphoblastic leukaemia, their outcome is often counterbalanced by the burden of toxic effects.
Attarbaschi, Andishe   +20 more
core   +2 more sources

Unique wreath-like smooth muscle proliferation of the pulmonary vasculature in pulmonary veno-occlusive disease versus pulmonary arterial hypertension

open access: yesJournal of the Formosan Medical Association, 2020
Background/purpose: Pulmonary veno-occlusive disease (PVOD) is a rare but fatal cause of pulmonary hypertension reported to be linked to mutations of eukaryotic initiation factor 2 alpha kinase 4 (EIF2AK4), also known as general control nonderepressible ...
Ying-Ju Lai   +3 more
doaj   +1 more source

Acute pulmonary hypertension caused by tumor embolism: a report of two cases. [PDF]

open access: yes, 2015
Acute pulmonary hypertension leading to right ventricular failure and circulatory collapse is usually caused by thromboembolic obstruction of the pulmonary circulation.
Liaudet, L.   +4 more
core   +1 more source

Co-existence of vocal cord dysfunction with pulmonary conditions other than asthma: A case series

open access: yesRespiratory Medicine Case Reports, 2018
Background: Vocal cord dysfunction (VCD) is defined as inappropriate movement of the vocal cords resulting in functional airway obstruction and symptoms including cough, wheezing, and dyspnea.
Merritt L. Fajt   +3 more
doaj   +1 more source

Targeting Vascular Remodeling to Treat Pulmonary Arterial Hypertension [PDF]

open access: yes, 2017
Pulmonary arterial hypertension (PAH) describes a group of conditions with a common hemodynamic phenotype of increased pulmonary artery pressure, driven by progressive remodeling of small pulmonary arteries, leading to right heart failure and death ...
Lawrie, A., Thompson, A.A.R.
core   +1 more source

Clinical features of canine pulmonary veno‐occlusive disease and pulmonary capillary hemangiomatosis

open access: yesJournal of Veterinary Internal Medicine, 2019
Background Histologic features of pulmonary veno‐occlusive disease (PVOD) and pulmonary capillary hemangiomatosis (PCH) have been described in dogs but without a thorough clinical description.
Carol R. Reinero   +5 more
doaj   +1 more source

Familial Pulmonary Capillary Hemangiomatosis Early in Life [PDF]

open access: yes, 2013
Background: Pulmonary capillary hemangiomatosis (PCH) is a rare disease, especially in infancy. Four infants have been reported up to the age of 12 months. So far, no familial patients are observed at this age.
Hebestreit, Helge   +4 more
core   +1 more source

The Endothelial CXCR Family in Vascular Health and Disease

open access: yesiNew Medicine, EarlyView.
ABSTRACT Endothelial cells (ECs) form the dynamic interface between blood and tissue, serving as key regulators of vascular homeostasis, inflammation, and repair. Among the molecular systems governing endothelial behavior, the C‐X‐C motif chemokine receptor (CXCR) family—originally characterized in immunology for its roles in leukocyte trafficking and ...
Zhiming Wu   +4 more
wiley   +1 more source

Pulmonary Veno-Occlusive Disease: A Rare Cause of Pulmonary Hypertension

open access: yesJournal of Investigative Medicine High Impact Case Reports, 2019
Pulmonary veno-occlusive disease (PVOD) is a rare entity that is usually mistaken with pulmonary arterial hypertension (PAH) but is considered class I′ of PAH. It is important to subclassify PVOD and distinguish it from PAH as treatment with vasodilators
Said Hajouli MD   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy